Adam Levin - Feb 4, 2022 Form 4 Insider Report for Ensysce Biosciences, Inc. (ENSC)

Role: Director
Signature: /s/ Adam Levin
Stock symbol: ENSC
Transactions as of: Feb 4, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/4/2022, 02:21 PM
Previous filing: Jul 2, 2021
Next filing: Jun 27, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENSC	Stock Option	Award		+20K			20K	Feb 4, 2022	Common Stock	20K	$3.13	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 4, 2022, Mr. Levin was granted an option (the "Stock Option") to purchase 20,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.01 per share, with an exercise price of $3.13, under the that certain Ensysce Biosciences, Inc. Amended and Restated 2021 Omnibus Incentive Plan. The Stock Option is scheduled to vest on the date of the Company's annual stockholder meeting in 2022.

Content

On February 4, 2022, Mr. Levin was granted an option (the "Stock Option") to purchase 20,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.01 per share, with an exercise price of $3.13, under the that certain Ensysce Biosciences, Inc. Amended and Restated 2021 Omnibus Incentive Plan. The Stock Option is scheduled to vest on the date of the Company's annual stockholder meeting in 2022.